Increased cannabis liberalization has resulted in a more active conversation about perinatal cannabis use, but globally, research and policy perspectives vary dramatically. This presentation will provide a summary of the endocannabinoid system, international rates of perinatal cannabis use, and varying beliefs about the use of cannabis as medicine across the globe. We will explore the published research on the potential health effects of perinatal cannabis use, highlighting physiologic harm reduction strategies. Beyond the health implications, we will discuss the relationship between professional organizational recommendations and the care pregnant and lactating families receive when healthcare policies reflect an abstinence-only approach. Any risk/benefit analysis about perinatal cannabis use should include the potential for significant legal and governmental intervention, which has its own set of outcomes and implications. Finally, the emerging science of high CBD/low THC products will be presented with an eye towards understanding the potential implications of perinatal CBD use.
Learning Objectives:
Objective 1. Discuss differences in rates of perinatal cannabis use across three different countries.
Objective 2. Recite recommendations about perinatal cannabis use by worldwide organizations.
Objective 3. List the differences between THC and CBD.
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
